Ahmed Magdy Rabea, Head of Medical Oncology Department at Shifa Hospital, shared a post on LinkedIn:
“I’m proud to share my recent contribution to a newly published article in Clinical Lymphoma, Myeloma & Leukemia (May 19, 2025):
“Practical Guidance on the Clinical Management of Belantamab Mafodotin for Patients with Relapsed/Refractory Multiple Myeloma: Recommendations from the Middle East and North Africa Expert Panel.”
This work provides practical insights and expert recommendations tailored to the management of belantamab mafodotin in relapsed/refractory multiple myeloma, specifically from the perspective of clinicians across the MENA region.
It’s been a privilege to collaborate with such a distinguished group of colleagues and experts in the field. Grateful for the opportunity to contribute to this important guidance.”
More posts featuring Ahmed Magdy Rabea.